$PLTR

Palantir stock slides amid slowdown in U.S. commercial bookings

Palantir's stock dropped 6.9% premarket Tuesday, despite strong Q3 results and raised full-year guidance, due to slower U.S. commercial bookings, according to analysts. The company's U.S. commercial revenue surpassed government revenue for the first time. (PLTR)

Original reporting
Published Nov 3, 2026, 9:56 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 9:59 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$PLTR
Bearish
medium confidence
Mentioned
$PLTR
Relevance
7/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$PLTRBearishHigh
01

Why it matters

The immediate price drop reflects market sensitivity to commercial demand trends, suggesting short‑term downside risk.

02

Market read

The move highlights investor focus on commercial booking health for high‑growth tech firms.

03

What to watch

Potential new government contracts or long‑term enterprise deals that are not reflected in short‑term booking data.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

Palantir reported robust Q3 earnings and upgraded full‑year guidance, but analysts noted a deceleration in U.S. commercial bookings, triggering a pre‑market sell‑off.

Company-level read

Ticker impact

$PLTRBearishMedium confidence
Context

Shares fell 6.9% pre‑market as analysts linked the drop to a slowdown in U.S. commercial bookings despite strong Q3 results.

Expected impact

likely further pressure as the market prices in weaker commercial demand

Evidence & confidence

A double‑digit pre‑market decline on a fresh catalyst suggests traders will stay cautious until the company clarifies the booking outlook.

Market effects

May weigh on other data‑analytics and AI‑software firms that rely on commercial contracts.

U.S. tech sector could see modest pullback as investors reassess commercial demand.

Limited; impact primarily confined to U.S. equities and Palantir‑related supply chain.

Counterpoint

The strong Q3 results and raised guidance could offset the booking slowdown, offering a buying opportunity on dip.

Key entities

  • Palantir Technologies Inc.

    U.S. data‑analytics and AI software provider.

Related articles

$AAPLMed

US Stock Futures Trade Mixed Premarket As AAPL Margin Concerns Weigh On Tech — PLTR, AMD, AEHR In Focus

US stock futures were mixed on Tuesday, with AAPL down 4.5% premarket due to margin concerns despite strong Q4 revenue. ORCL rose 0.4% after a $20B share sale plan. PLTR fell 5% despite beating earnings. NVDA gained 1.3%, MRVL up 2% on acquisition news, AMD up 2.4% ahead of earnings. AEHR surged 15.5% on record revenue and strong outlook. Midterm elections and earnings calendar also in focus.

$PLTRMedAI 8/10

PLTR Q3 deep dive: U.S. commercial outpaces government as Sovereign AI drives adoption

Palantir (PLTR) reported Q3 2026 revenue of $2.31B, up 95.9% YoY, and raised Q4 guidance to $2.65B, 7.6% above estimates. Non-GAAP EPS was $0.44, 8.4% above consensus. U.S. commercial revenue surpassed government revenue for the first time, driven by Sovereign AI adoption. Management expects continued growth but notes scaling challenges. The stock traded at $172.99 post-earnings, down from $178.30.

$PLTRHighAI 8/10

Why is Palantir Technologies stock sliding today?

Palantir Technologies (PLTR) stock fell 6.0% in pre-market trading to $167.66 after Q3 2026 results. Revenue grew 96% YoY to $2.31B, beating estimates, but contract momentum slowed, raising concerns about future growth. Analysts noted the valuation remains high despite a price target increase to $233 by Morgan Stanley. Insider selling and sector-wide scrutiny added to the pressure.

$PLTRHighAI 8/10

Mizuho reiterates Palantir stock rating on strong revenue growth

Mizuho reiterated an Outperform rating and $245 price target for Palantir (PLTR) after Q3 results showed 96% year-over-year revenue growth, exceeding estimates. U.S. Commercial revenue surpassed Government revenue for the first time. Management raised 2026 revenue growth guidance. Analysts praised Palantir's growth and margins, with several raising price targets.

$PLTRMedAI 8/10

Piper Sandler raises Palantir stock price target to $235 on revenue growth

Piper Sandler raised its price target for Palantir (PLTR) to $235, citing strong revenue growth and a shift in revenue sources. U.S. Commercial revenue surpassed U.S. Government revenue for the first time, growing 148% year-over-year. The company reported Q3 2026 revenue of $2.31 billion, up 96% year-over-year, and adjusted EPS of $0.44. Several analysts raised their price targets following the results.